Additionally, new in vitro data also show Brilacidin targets both viral proteins and host factors, suggesting Brilacidin would be less
Read more
46% complete response of patients at Melanoma Institute Australia Fifth published study of in-transit melanoma lesion treatment with single-agent PV-10
Read more
MONTREAL, March 01, 2021 (GLOBE NEWSWIRE) — Sunshine Biopharma Inc. (OTC PINK: “SBFM”), a leader in nutrition research and development
Read more
SAN FRANCISCO, CA, Feb. 03, 2021 (GLOBE NEWSWIRE) — via NewMediaWire – Oncology Pharma, Inc. (OTC: ONPH) is pleased to announce that it has
Read more
VANCOUVER, British Columbia, Nov. 30, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or
Read more
VANCOUVER, British Columbia, Nov. 23, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or
Read more
VANCOUVER, British Columbia, Nov. 13, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or
Read more
WAKEFIELD, Mass., Nov. 02, 2020 (GLOBE NEWSWIRE) — Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, announced today
Read more
SOUTH SAN FRANCISCO, CA–(Marketwired – Oct 8, 2015) – Titan Pharmaceuticals, Inc. (OTCQB: TTNPD), a specialty pharmaceutical company developing proprietary therapeutics
Read more
PR Newswire TEL AVIV, Israel and BETHESDA, Maryland, Oct. 27, 2020 TEL AVIV, Israel and BETHESDA, Maryland, Oct. 27, 2020 /PRNewswire/ — Cannabics Pharmaceuticals Inc.
Read more
WAKEFIELD, Mass., April 20, 2020 (GLOBE NEWSWIRE) — Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased
Read more
DALLAS, TX (Uptick Newswire – February 12, 2018) — Rocky Mountain High Brands, Inc. (OTCQB:RMHB), a fully reporting consumer goods
Read more